Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase EARLY_PHASE1 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Myeloid 3Lymphoid 3Other hematologic neoplasm 2Plasma cell 1

Conditions

Carcinoma, Non-Small-Cell Lung 145Parkinson Disease 4, Autosomal Dominant Lewy Body 120Melanoma 84Squamous Cell Carcinoma of Head and Neck 56Neoplasms 44Breast Neoplasms 41Stomach Neoplasms 39Colorectal Neoplasms 38Triple Negative Breast Neoplasms 37Neoplasm Metastasis 36Carcinoma, Renal Cell 36Ovarian Neoplasms 30Lung Neoplasms 30Head and Neck Neoplasms 29Urinary Bladder Neoplasms 28Carcinoma, Transitional Cell 26Carcinoma, Hepatocellular 26Pancreatic Neoplasms 23Esophageal Neoplasms 20Endometrial Neoplasms 16Recurrence 15Prostatic Neoplasms 15Multiple Myeloma 15Fallopian Tube Neoplasms 15Carcinoma 14Sarcoma 13Lymphoma, Large B-Cell, Diffuse 13Small Cell Lung Carcinoma 12Lymphoma, Follicular 12Lymphoma, Non-Hodgkin 11

Interventions

fludarabine phosphate 87Cyclophosphamide 78Whole-Body Irradiation 59Azacitidine 59fludarabine 56Mycophenolic Acid 56Busulfan 53Tacrolimus 51Peripheral Blood Stem Cell Transplantation 41Melphalan 40Cytarabine 38Antilymphocyte Serum 38Filgrastim 37Granulocyte Colony-Stimulating Factor 33Cyclosporine 33Methotrexate 32Decitabine 32thymoglobulin 22Thiotepa 21Clofarabine 21Cord Blood Stem Cell Transplantation 19Stem Cell Transplantation 16Alemtuzumab 16Sirolimus 15Rituximab 15sargramostim 12Lenalidomide 12Etoposide 11Radiotherapy 10Cyclosporins 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Myelodysplastic Syndromes × pembrolizumab × Clear all
NCT03286114 2025-05-11

Augmentation of the Graft vs. Leukemia Effect Via Checkpoint Blockade With Pembrolizumab

University of Michigan Rogel Cancer Center

Phase 1 Terminated
16 enrolled 13 charts
LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02981914 2024-04-22

Pilot Study of Pembrolizumab Treatment for Disease Relapse After Allogeneic Stem Cell Transplantation

University of Chicago

Phase EARLY_PHASE1 Completed
12 enrolled 11 charts
LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Lymphoma, B-Cell

NCT01953692 2021-08-04

MK-3475-013

Merck Sharp & Dohme LLC

Phase 1 Completed
197 enrolled 52 charts
LymphoidMyeloidPlasma cell

Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡